AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Niagen Bioscience, Inc. Director's Dealing 2010

May 26, 2010

32418_dirs_2010-05-26_10e93cf2-29ab-4c42-8c7a-3f6111b52b80.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2010-05-20

Reporting Person: HALPRYN GLENN L (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	535714	Indirect

Footnotes

F1: This Form 3 is being filed solely to correct Item 2 "Date of Event Requiring Statement" in the identification section of the Form 3 filed by the Reporting Person on May 24, 2010. The correct event date is 05/20/2010.